Hemagglutinin Nanoparticulate Vaccine with Controlled Photochemical Immunomodulation for Pathogenic Influenza‐Specific Immunity

Hemagglutinin Nanoparticulate Vaccine with Controlled Photochemical Immunomodulation for Pathogenic Influenza‐Specific Immunity

Abstract Recently, viral infectious diseases, including COVID‐19 and Influenza, are the subjects of major concerns worldwide. One strategy for addressing these concerns focuses on nasal vaccines, which have great potential for achieving successful immunization via safe, easy, and affordable approach...

Full description

Bibliographic Details
Main Authors: Hayoon Jeong, Chung‐Sung Lee, Jangsu Lee, Jonghwan Lee, Hee Sook Hwang, Min Lee, Kun Na
Format: Article
Language:English
Published: Wiley 2021-12-01
Series:Advanced Science
Subjects:
influenza virus
nanovaccine
nasal antigen delivery
nasal vaccine
photochemical immunomodulation
Online Access:https://doi.org/10.1002/advs.202100118

Internet

https://doi.org/10.1002/advs.202100118

Similar Items